Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial
Language English Country United States Media print-electronic
Document type Letter, Comment
PubMed
35838268
DOI
10.1097/ccm.0000000000005555
PII: 00003246-202208000-00026
Knihovny.cz E-resources
- MeSH
- Hyperthermia, Induced * MeSH
- Intensive Care Units MeSH
- Critical Illness therapy MeSH
- Humans MeSH
- Pilot Projects MeSH
- Randomized Controlled Trials as Topic MeSH
- Sepsis * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
See more in PubMed
Drewry AM, Mohr NM, Ablordeppey EA, et al.: Therapeutic hyperthermia is associated with improved survival in afebrile critically ill patients with sepsis: A pilot randomized trial. Crit Care Med. 2022; 50:924–934
Guihur A, Rebeaud ME, Fauvet B, et al.: Moderate fever cycles as a potential mechanism to protect the respiratory system in COVID-19 patients. Front Med (Lausanne). 2020; 7:564170
Wu C, Li H, Zhang P, et al.: Lymphatic flow: A potential target in sepsis-associated acute lung injury. J Inflamm Res. 2020; 13:961–968
Yasuda A, Ohshima N, et al.: In situ observations of spontaneous contractions of the peripheral lymphatic vessels in the rat mesentery: Effects of temperature. Experientia. 1984; 40:342–343
